openPR Logo
Press release

The Intravitreal (IVT) Injectable Market to grow at a CAGR of 4.9% between 2022-2028

08-08-2022 06:34 AM CET | Health & Medicine

Press release from: Persistence Market Research

The Intravitreal (IVT) Injectable Market to grow at a CAGR of 4.9%

The Intravitreal Ivt Injectable Market is bound to reach US$ 23,814.3 Mn at a CAGR of 4.9% between 2018-2028. The current scenario is such that on-demand healthcare storage is being asked for. Cloud computing thus curtails operational expenses and capital as it simplifies sharing medical records, creates and maintains telehealth apps, and automates backend operations. This would be the scene with the healthcare vertical in the upcoming period.

According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value.

Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete blindness. Intravitreal injection is a safe and easy method of treating retinal disorders.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25906

Company Profiles:
• F. Hoffmann-La Roche Ltd
• Regeneron Pharmaceuticals, Inc.
• Bausch & Lomb
• Novartis AG
• Allergan
• Alimera Sciences
• ThromboGenics, Inc.
• Bristol-Myers Squibb Company

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25906

According to the National Eye Institute (NEI), around 2.0 million people in the United States were afflicted by AMD in 2010, with the figure anticipated to more than increase to 5.4 million by 2050. To address rising demand, industry players are focused on innovation by developing a solid pipeline of IVT injections for the treatment of retinal diseases.

Between 2022 and 2028, North America is expected to account for a significant share of the global market. Increased incidence of age-related macular degeneration (AMD) is expected to stimulate demand for intravitreal (IVT) injectables in the United States.

Due to an increase in the elderly population and an increase in the incidence of retinal illnesses, the European market is also expected to fuel market growth. In the coming years, countries such as India and China are likely to boost demand for intravitreal (IVT) injectables in the Asia Pacific region, due to the presence of a sizable patient pool suffering from diabetes mellitus.

Want More Insights?
PMR has presented a comprehensive report based on Intravitreal (IVT) Injectable Market as per Indication (Diabetic Retinopathy, Macular Degeneration, Endophthalmitis, Retinal Vein Occlusions and Others), Drug Class (Anti-VEGF, Corticosteroids, Antibiotics, Antivirals and Antifungals), Distributional Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies and Others), based on seven regions.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25906

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Intravitreal (IVT) Injectable Market to grow at a CAGR of 4.9% between 2022-2028 here

News-ID: 2699813 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for IVT

The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value. Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete
Consumer-Facing Telemedicine To Drive The Intravitreal (IVT) Injectable Market, …
The Intravitreal Ivt Injectable Market is bound to reach US$ 23,814.3 Mn at a CAGR of 4.9% between 2018-2028. The current scenario is such that on-demand healthcare storage is being asked for. Cloud computing thus curtails operational expenses and capital as it simplifies sharing medical records, creates and maintains telehealth apps, and automates backend operations. This would be the scene with the healthcare vertical in the upcoming period. According to the
The Intravitreal IVT Injectable Market to Witness Invigorating Trends
The Intravitreal IVT Injectable Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing
The Intravitreal IVT Injectable Market to Gloat Over Advancement in Healthcare M …
The Intravitreal IVT Injectable Market is likely to grow stupendously in the subsequent decade. With IoT in the picture, the complex medical equipment could be monitored, that too, all at a time and under one umbrella. As such, costly downtime could be avoided and predictive maintenance could be fostered. Plus, increased spending could be facilitated for disposable items like syringes, gloves, and masks. Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25906 Retinal diseases
The Intravitreal IVT Injectable Market to grow on an invincible note
The Intravitreal IVT Injectable Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology’s medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously. Hereditary retinal diseases is the major
Global Intravitreal (IVT) Injectables Market : Rising Allocations On analysis  …
Albany, NY, 18th April : Recent research and the current scenario as well as future market potential of "Global Market Study on Intravitreal (IVT) Injectables: Chronic Retinal Conditions to Uplift Sales of Anti-VEGF IVT Injectables" globally. Recently published report titled ‘Intravitreal (IVT) Injectables Market: Global Industry Analysis 2013 – 2017 and Forecast 2018–2028' offers a comprehensive assessment of the key dynamics pertaining to the intravitreal (IVT) injectables market. The report presents